Article
Low skeletal muscle radiodensity predicts response to avelumab maintenance treatment in patients with metastatic urothelial carcinoma
2026-01-27
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> The JAVELIN Bladder 100 trial demonstrated a significant survival benefit of avelumab maintenance therapy over best supportive care in patients with locally advanced or metastatic urothelial carcinoma (la/mUC) who achieved disease control after platinum-based chemotherapy. Although avelumab maintenance therapy is generally well tolerated, some patients experi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8465b9a2-d607-5305-99ee-9252b240a068
- DOI
- 10.21203/rs.3.rs-8486641/v1
